EssilorLuxottica (OTCMKTS:ESLOY) Sets New 12-Month Low - Here's Why

Key Points

• EssilorLuxottica's ADR hit a new 52-week low, trading as low as $100.35 (last $101.95) on volume of 75,959 shares, well below its 50-day ($118.95) and 200-day ($150.14) moving averages.
• Analysts have recently upgraded the stock—Kepler Capital Markets and HSBC moved to "buy"—giving an average MarketBeat rating of Buy (2 Strong Buys, 5 Buys, 1 Hold).
• The company has low leverage (debt-to-equity 0.17) but relatively tight liquidity (current ratio 0.99, quick ratio 0.70), a factor investors may weigh as the share price trades near year lows.

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as $100.35 and last traded at $101.95, with a volume of 75959 shares trading hands. The stock had previously closed at $107.50.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Kepler Capital Markets raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research note on Thursday, January 15th. HSBC upgraded shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a report on Wednesday, January 14th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy".

EssilorLuxottica Price Performance

The stock's 50-day moving average price is $118.95 and its 200-day moving average price is $150.14. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.